The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...
Brain metastases (BM) are a severe complication of multiple primary malignancies and constitute the most frequent tumors of the central nervous system. Clinical imaging plays a crucial role in the ...
AMBELVIST ® (gadoquatrane) is a gadolinium-based contrast agent indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and ...
Brain MRI is the primary imaging modality for pediatric brain tumors, yet incomplete acquisitions are common, hindering the clinical utility of existing deep learning models for tumor segmentation and ...
Magnetic resonance imaging (MRI) is a noninvasive imaging technology that provides your doctor with a three-dimensional, detailed anatomical image, typically of a specific part of your body, that’s ...
The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results